NCT02051751 2020-12-08A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck CancerNovartisPhase 1 Completed19 enrolled
NCT00667641 2011-05-10Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsRutgers, The State University of New JerseyPhase 1 Completed16 enrolled